16 Followers on Owler

NextCure

is a biopharmaceutical company that researches and develops immuno-medicines for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

NextCure

is a biopharmaceutical company that researches and develops immuno-medicines for the treatment of cancer... Read more
NextCure President & CEO: Michael Richman

President & CEO

Michael Richman

CEO Approval Rating

48/100

2015

PublicNASDAQNXTC

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$48.3M
Employees
90
Funding
$181.9M

News

Conference Presentation
Nov 20, 2025
Benzinga
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
Funding
Nov 17, 2025
GlobalNewswire
NextCure received $21.5M in PIPE Funding

NextCure Competitors

1NexImmune
2Silverback Therapeutics
3Aura
4AstraZeneca
5Daiichi Sankyo
6bluebird bio
7Bristol-Myers Squibb
8ImmunityBio
9Byondis
10Mustang Bio
Unlock 37 + competitors

Trending Companies